A

Atlanta Center for Medical Research | Atlanta, GA

Research site
(Unclaimed)
Location
501 Fairburn Road, SW, Atlanta, Georgia, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

15 of 200
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

A clinical study that will evalute how well SEP-363856 works and how safe it is in people with schizophrenia that switch to SEP-363856 from their cur...

Active, not recruiting
Schizophrenia
Drug: SEP-363856

The purpose of this study is to show that high-dose quadrivalent seasonal influenza vaccine (HD QIV) given together with 9-valent extraintestinal pat...

Active, not recruiting
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Biological: ExPEC9V
Biological: Placebo

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

The purpose of this study is to determine if NaBen® is a safe and effective add-on treatment for schizophrenia in adolescents.

Enrolling
Schizophrenia
Drug: NaBen®
Drug: Placebo

This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in d...

Active, not recruiting
Schizophrenia
Drug: Xanomeline and Trospium Chloride Capsules

The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.

Enrolling
Schizophrenia
Drug: Placebo
Drug: Cariprazine
Locations recently updated

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Enrolling
Treatment Resistant Depression
Drug: Psilocybin

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Enrolling
Painful Lumbosacral Radiculopathy
Drug: VX-548
Drug: Placebo

The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants wit...

Enrolling
Parkinson Disease
Drug: Lu AF28996

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Enrolling
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose
Locations recently updated

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

A Phase 3, randomized, double-blind, placebo-controlled, multi-center, fixed-dose, parallel-group efficacy and safety study in a pediatric population...

Active, not recruiting
Attention Deficit Hyperactivity Disorder Combined
Attention Deficit Hyperactivity Disorder
Drug: CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Drug: CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose)

To demonstrate HSK3486 0.4/0.2 mg/kg (0.4 mg/kg intravenous [IV] slow injection over 30 [±5] seconds for the first dose, an additional 0.2 mg/kg if n...

Enrolling
General Anesthesia
Drug: HSK3486
Drug: Propofol

This is a study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of FTX-6058 in participants with sickle cell disease.

Enrolling
Sickle Cell Anemia
Sickle Cell Disease
Drug: FTX-6058 oral capsule(s)

Autism spectrum disorder (ASD) consists of deficits in social, communication, and cognitive development, repetitive and stereotypic behaviors. Many A...

Enrolling
Autism Spectrum Disorder
Drug: Placebo
Drug: Cariprazine

Trial conditions

Schizophrenia (49 trials)
Depression (45 trials)
Depressive Disorder (44 trials)
Major Depressive Disorder (38 trials)
Attention Deficit Disord... (17 trials)
Hyperkinesis (16 trials)
Parkinson Disease (15 trials)
Alzheimer Disease (14 trials)
Psychotic Disorders (10 trials)
Cognitive Dysfunction (6 trials)

And 72 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems